Translational Research Partnerships Unit

Introduction

VP Photo 002 

 Dr Valeria Pavet

Head of Translational Research Partnerships Unit

V.Pavet@crukscotlandinstitute.ac.uk

The path from fundamental scientific discoveries to their application as treatments to improve people’s health is often complex, long and costly as many diverse areas of expertise are required to work in concert to achieve this goal. At the Translational Research Collaborations Unit (TRCU), we approach this challenging process by promoting interactions between discovery and applied research, and between academia and industry.

As part of the CRUK Scotland Institute and the CRUK Scotland Centre, our mission is to support the translation of scientific discoveries into treatments that benefit cancer patients. We do this by searching for the most suitable path, including:

  • Supporting the establishment of collaborations between research group leaders and academic/industry partners for progressing preclinical translational work withina group leader’s laboratory.
  • Finding external funding and partnerships with industry for our TRCU experimental team to run preclinical translational research projects testing novel approaches to combat cancer.

Experimental work developed within the TRCU leverages the comprehensive suite of preclinical in vitro and in vivo experimental models at the CRUK Scotland Institute, spanning different cancer types, subtypes and stages and including amongst others colorectal, hepatocellular, pancreatic and ovarian cancer. Work developed by the TRCU is supported by state-of-the art animal facilities and technology platforms (link here to advanced technology pages?) and by wide network of fundamental and clinician scientists contributing to our programmes.

By bringing together the knowledge generated by scientists at the CRUK Scotland Institute and CRUK Scotland Centre with the pharmaceutical research and development expertise of colleagues in industry, we hope to create a synergistic environment to better understand the biology of cancer and increase our societal impact on healthcare.

To learn more about our experimental models and collaboration schemes, please email: v.pavet@crukscotlandinstitute.ac.uk

For collaboration agreements, NDAs, CDAs, MTAs, etc. please email: CRUKSI-CA@crukscotlandinstitute.ac.uk